SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Feb 21, 2019
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-02-19+400,000→ 400,000 totalExercise: $0.95Exp: 2029-02-19→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the Option shall vest on the one year anniversary of February 19, 2019, and 1/3 of the shares shall vest annually thereafter on February 19, subject to Reporting Person continuing to be an employee or service provider on each date, such that the Option shall be fully vested on February 19, 2022.